EXANE DERIVATIVES

Q3 2019 13F Holdings Report, Stock Holdings

Signature - Title
Corinne FLECK - Head of Regulatory affairs and reportings
Location
Paris, France
Holdings as of
30 Sep 2019
Value $
$510M
Num holdings
621
Filing time
15 Oct 2019, 12:36:41 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included UBS, FCAU, RACE, RSX, and DB.
Previous filing
Q2 2019 - 12 Jul 2019
Next filing
Q4 2019 - 22 Jan 2020
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q3 compared to 2019 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Corinne FLECK Head of Regulatory affairs and reportings Paris, France 15 Oct 2019